{"transactions":[{"id":1138825,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-21T17:30:05.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":23917,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 20, 2026 or (b) the date of the 2026 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 23,917 restricted stock units."}],"balance_after":1096861,"source":{"system":"sec-edgar","filing":"0000950170-25-075889","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000095017025075889/ownership.xml","form_type":"4"}},{"id":1500128,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-28T16:30:14.000Z","date":"2024-05-24","kind":"purchase","planned":false,"acquired":true,"shares":18000,"price":5.1945,"value":93501.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $5.1200 to $5.2400 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 15,091 restricted stock units."}],"balance_after":1072944,"source":{"system":"sec-edgar","filing":"0000950170-24-065263","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000095017024065263/ownership.xml","form_type":"4"}},{"id":1503417,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-23T16:30:28.000Z","date":"2024-05-22","kind":"purchase","planned":false,"acquired":true,"shares":12100,"price":4.9938,"value":60424.98,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.9600 to $5.0000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 15,091 restricted stock units."}],"balance_after":1054944,"source":{"system":"sec-edgar","filing":"0000950170-24-063988","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000095017024063988/ownership.xml","form_type":"4"}},{"id":1505227,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-22T17:30:23.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":33260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option will vest in 12 substantially equal monthly installments, commencing on June 21, 2024, such that the stock option will be fully vested and exercisable on the earlier of (a) May 21, 2025, or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date."}],"balance_after":33260,"derivative":{"exercise_price":4.97,"expiration_date":"2034-05-21","underlying":"Common Stock","underlying_shares":33260},"source":{"system":"sec-edgar","filing":"0000950170-24-063614","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000095017024063614/ownership.xml","form_type":"4"}},{"id":1505226,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-22T17:30:23.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":15091,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 21, 2025 or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 15,091 restricted stock units."}],"balance_after":1042844,"source":{"system":"sec-edgar","filing":"0000950170-24-063614","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000095017024063614/ownership.xml","form_type":"4"}},{"id":1518909,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-13T19:48:45.000Z","date":"2024-05-13","kind":"purchase","planned":false,"acquired":true,"shares":36802,"price":4.3772,"value":161089.7144,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.320 to $4.5900 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,753 restricted stock units"}],"balance_after":1027753,"source":{"system":"sec-edgar","filing":"0000950170-24-058989","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000095017024058989/ownership.xml","form_type":"4"}},{"id":1518908,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-13T19:48:45.000Z","date":"2024-05-10","kind":"purchase","planned":false,"acquired":true,"shares":83198,"price":4.5656,"value":379848.7888,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.4000 to $4.6500 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,753 restricted stock units"}],"balance_after":990951,"source":{"system":"sec-edgar","filing":"0000950170-24-058989","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000095017024058989/ownership.xml","form_type":"4"}},{"id":1877802,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-25T21:00:33.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":6305,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option will vest in 12 substantially equal monthly installments, commencing on June 23, 2023, such that the stock option will be fully vested and exercisable on the earlier of (a) May 23, 2024, or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date."}],"balance_after":6305,"derivative":{"exercise_price":26.34,"expiration_date":"2033-05-23","underlying":"Common Stock","underlying_shares":6305},"source":{"system":"sec-edgar","filing":"0001209191-23-032351","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000120919123032351/doc4.xml","form_type":"4"}},{"id":1877801,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-25T21:00:33.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":2753,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 23, 2024 or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date.  The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $26.0000 to $26.0200 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Includes 2,753 RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,753 RSUs."}],"balance_after":907753,"source":{"system":"sec-edgar","filing":"0001209191-23-032351","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000120919123032351/doc4.xml","form_type":"4"}},{"id":1922222,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-10T21:00:06.000Z","date":"2023-04-06","kind":"sale","planned":false,"acquired":false,"shares":4043,"price":26.0008,"value":105121.2344,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $26.0000 to $26.0200 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,295 RSUs."}],"balance_after":905000,"source":{"system":"sec-edgar","filing":"0001209191-23-023948","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000120919123023948/doc4.xml","form_type":"4"}},{"id":1924762,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-05T21:00:13.000Z","date":"2023-04-04","kind":"sale","planned":false,"acquired":false,"shares":15756,"price":26.0007,"value":409667.0292,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.0000 to $25.9050 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,295 RSUs."}],"balance_after":909043,"source":{"system":"sec-edgar","filing":"0001209191-23-023543","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000120919123023543/doc4.xml","form_type":"4"}},{"id":1924761,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-05T21:00:13.000Z","date":"2023-04-03","kind":"sale","planned":false,"acquired":false,"shares":201,"price":26,"value":5226.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,295 RSUs."}],"balance_after":924799,"source":{"system":"sec-edgar","filing":"0001209191-23-023543","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000120919123023543/doc4.xml","form_type":"4"}},{"id":1933820,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-31T21:00:16.000Z","date":"2023-03-31","kind":"sale","planned":false,"acquired":false,"shares":95000,"price":25.3582,"value":2409029.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.0000 to $25.9050 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,295 RSUs."}],"balance_after":925000,"source":{"system":"sec-edgar","filing":"0001209191-23-021956","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000120919123021956/doc4.xml","form_type":"4"}},{"id":1933819,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-31T21:00:16.000Z","date":"2023-03-30","kind":"sale","planned":false,"acquired":false,"shares":38498,"price":26.0013,"value":1000998.0474,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $26.000 to $26.0200 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,295 RSUs."}],"balance_after":1020000,"source":{"system":"sec-edgar","filing":"0001209191-23-021956","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000120919123021956/doc4.xml","form_type":"4"}},{"id":1958546,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-10T21:00:09.000Z","date":"2023-03-09","kind":"sale","acquired":false,"shares":1502,"price":26,"value":39052.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,295 RSUs."}],"balance_after":1058498,"source":{"system":"sec-edgar","filing":"0001209191-23-018040","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000120919123018040/doc4.xml","form_type":"4"}},{"id":1958545,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-10T21:00:09.000Z","date":"2023-03-08","kind":"sale","acquired":false,"shares":20000,"price":24.0001,"value":480002.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.0000 to $24.0100 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,295 RSUs."}],"balance_after":1060000,"source":{"system":"sec-edgar","filing":"0001209191-23-018040","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000120919123018040/doc4.xml","form_type":"4"}},{"id":1958544,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-10T21:00:09.000Z","date":"2023-03-08","kind":"sale","acquired":false,"shares":25000,"price":22.5,"value":562500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,295 RSUs."}],"balance_after":1080000,"source":{"system":"sec-edgar","filing":"0001209191-23-018040","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000120919123018040/doc4.xml","form_type":"4"}},{"id":1972454,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-03T21:00:16.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":50000,"price":21.3509,"value":1067545.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $21.2000 to $21.5500 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,295 RSUs."}],"balance_after":1105000,"source":{"system":"sec-edgar","filing":"0001209191-23-016093","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000120919123016093/doc4.xml","form_type":"4"}},{"id":2032541,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-03T21:00:16.000Z","date":"2023-02-02","kind":"sale","acquired":false,"shares":4011,"price":24,"value":96264.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,295 RSUs."}],"balance_after":1155000,"source":{"system":"sec-edgar","filing":"0001209191-23-007201","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000120919123007201/doc4.xml","form_type":"4"}},{"id":2041992,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-30T18:30:31.000Z","date":"2023-01-30","kind":"sale","acquired":false,"shares":2039,"price":24.5809,"value":50120.4551,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.4150 to $25.1300 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,295 RSUs."}],"balance_after":1159011,"source":{"system":"sec-edgar","filing":"0001209191-23-005543","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000120919123005543/doc4.xml","form_type":"4"}},{"id":2041991,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-30T18:30:31.000Z","date":"2023-01-30","kind":"sale","acquired":false,"shares":27422,"price":23.8714,"value":654601.5308,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.4100 to $24.4000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,295 RSUs."}],"balance_after":1161050,"source":{"system":"sec-edgar","filing":"0001209191-23-005543","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000120919123005543/doc4.xml","form_type":"4"}},{"id":2041990,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-30T18:30:31.000Z","date":"2023-01-30","kind":"sale","acquired":false,"shares":61528,"price":22.9237,"value":1410449.4136,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.4000 to $23.3950 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,295 RSUs."}],"balance_after":1188472,"source":{"system":"sec-edgar","filing":"0001209191-23-005543","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000120919123005543/doc4.xml","form_type":"4"}},{"id":2050590,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-19T21:00:14.000Z","date":"2023-01-17","kind":"sale","acquired":false,"shares":11014,"price":26.0012,"value":286377.2168,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $26.0000 to $26.0400 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,295 RSUs."}],"balance_after":1250000,"source":{"system":"sec-edgar","filing":"0001209191-23-004143","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000120919123004143/doc4.xml","form_type":"4"}},{"id":2054574,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-13T21:00:23.000Z","date":"2023-01-13","kind":"sale","acquired":false,"shares":6519,"price":26.0001,"value":169494.6519,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $26.0000 to $26.0075 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,295 RSUs."}],"balance_after":1261014,"source":{"system":"sec-edgar","filing":"0001209191-23-003384","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000120919123003384/doc4.xml","form_type":"4"}},{"id":2054573,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-13T21:00:23.000Z","date":"2023-01-12","kind":"sale","acquired":false,"shares":42467,"price":26.0006,"value":1104167.4802,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $26.000 to $26.0200 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,295 RSUs."}],"balance_after":1267533,"source":{"system":"sec-edgar","filing":"0001209191-23-003384","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000120919123003384/doc4.xml","form_type":"4"}},{"id":2058613,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-09T21:00:13.000Z","date":"2023-01-09","kind":"sale","acquired":false,"shares":10444,"price":24.002,"value":250676.888,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.0000 to $24.0800 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,295 RSUs."}],"balance_after":1310000,"source":{"system":"sec-edgar","filing":"0001209191-23-002675","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000120919123002675/doc4.xml","form_type":"4"}},{"id":2058612,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-09T21:00:13.000Z","date":"2023-01-05","kind":"sale","acquired":false,"shares":9556,"price":24.002,"value":229363.112,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.0000 to $24.0400 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,295 RSUs."}],"balance_after":1320444,"source":{"system":"sec-edgar","filing":"0001209191-23-002675","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000120919123002675/doc4.xml","form_type":"4"}},{"id":2074122,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-30T21:00:12.000Z","date":"2022-12-30","kind":"sale","acquired":false,"shares":75000,"price":22.6723,"value":1700422.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.3800 to $23.3000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,295 RSUs."}],"balance_after":1330000,"source":{"system":"sec-edgar","filing":"0001209191-22-063055","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000120919122063055/doc4.xml","form_type":"4"}},{"id":2097963,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-02T21:00:24.000Z","date":"2022-12-01","kind":"sale","acquired":false,"shares":20000,"price":24,"value":480000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.000 to $24.110 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1405000,"source":{"system":"sec-edgar","filing":"0001209191-22-059533","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000120919122059533/doc4.xml","form_type":"4"}},{"id":2097962,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-02T21:00:24.000Z","date":"2022-11-30","kind":"sale","acquired":false,"shares":75000,"price":21.904,"value":1642800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $21.600 to $22.220 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1425000,"source":{"system":"sec-edgar","filing":"0001209191-22-059533","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000120919122059533/doc4.xml","form_type":"4"}},{"id":2128331,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-01T19:00:13.000Z","date":"2022-10-31","kind":"sale","acquired":false,"shares":95000,"price":23.5677,"value":2238931.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.20 to $24.04 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1500000,"source":{"system":"sec-edgar","filing":"0001209191-22-055133","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000120919122055133/doc4.xml","form_type":"4"}},{"id":2263345,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-19T20:37:15.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":16625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest in 12 substantially equal monthly installments, commencing on June 17, 2022, such that the stock option will be fully vested and exercisable on May 17, 2023, subject to Reporting Person's providing continued service to Issuer through the vesting date."}],"balance_after":16625,"derivative":{"exercise_price":15.8,"expiration_date":"2032-05-17","underlying":"Common Stock","underlying_shares":16625},"source":{"system":"sec-edgar","filing":"0001567619-22-011343","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000156761922011343/doc1.xml","form_type":"4"}},{"id":2263344,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-19T20:37:15.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":2295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on May 17, 2023 subject to Reporting Person's providing continued service to Issuer through the vesting date."}],"balance_after":1595000,"source":{"system":"sec-edgar","filing":"0001567619-22-011343","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000156761922011343/doc1.xml","form_type":"4"}},{"id":2339545,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-10T20:25:12.000Z","date":"2022-03-10","kind":"gift","acquired":false,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1592705,"source":{"system":"sec-edgar","filing":"0001567619-22-006731","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000156761922006731/doc1.xml","form_type":"4"}},{"id":2735665,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-04-29T21:16:11.000Z","date":"2021-04-27","kind":"exercise","acquired":false,"shares":699141,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":699141},"source":{"system":"sec-edgar","filing":"0000899243-21-017476","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000089924321017476/doc4.xml","form_type":"4"}},{"id":2735664,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-04-29T21:16:11.000Z","date":"2021-04-27","kind":"other","acquired":true,"shares":16180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend."}],"balance_after":699141,"derivative":{"underlying":"Common Stock","underlying_shares":16180},"source":{"system":"sec-edgar","filing":"0000899243-21-017476","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000089924321017476/doc4.xml","form_type":"4"}},{"id":2735663,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-29T21:16:11.000Z","date":"2021-04-27","kind":"exercise","acquired":true,"shares":699141,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."}],"balance_after":1697705,"source":{"system":"sec-edgar","filing":"0000899243-21-017476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000089924321017476/doc4.xml","form_type":"4"}},{"id":2739458,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Right to Buy","published_at":"2021-04-26T21:01:53.000Z","date":"2021-04-22","kind":"grant","acquired":true,"shares":21240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in 12 substantially equal installments, commencing on May 22, 2021, such that the stock option will be fully vested and exercisable on April 22, 2022, subject to Reporting Person's providing continued service to Issuer through each vesting date."}],"balance_after":21240,"derivative":{"exercise_price":17,"expiration_date":"2031-04-22","underlying":"Common Stock","underlying_shares":21240},"source":{"system":"sec-edgar","filing":"0000899243-21-017034","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000089924321017034/doc4.xml","form_type":"4"}}]}